Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy

[1]  S. Fulda,et al.  Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase. , 2005, Cancer research.

[2]  B. Shen,et al.  A Novel eIF5A Complex Functions As a Regulator of p53 and p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.

[3]  W. Hohenberger,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[4]  Akhilesh Pandey,et al.  Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags , 2004, Cancer biology & therapy.

[5]  C. Belka,et al.  Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. , 2004, International journal of radiation oncology, biology, physics.

[6]  J. Hershey,et al.  Identification and characterization of eukaryotic initiation factor 5A-2. , 2003, European journal of biochemistry.

[7]  B. Bittorf,et al.  P27 does not predict histopathological response to radiochemotherapy in rectal cancer. , 2003, The Journal of surgical research.

[8]  S. Clarke,et al.  p53, Deleted in Colorectal Cancer Gene, and Thymidylate Synthase as Predictors of Histopathologic Response and Survival in Low, Locally Advanced Rectal Cancer Treated With Preoperative Adjuvant Therapy , 2003, Diseases of the colon and rectum.

[9]  J. Kofron,et al.  Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway , 2003, Science.

[10]  G. Noël,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer , 2002 .

[11]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[12]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[13]  Rieken,et al.  [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[14]  H. Sasaki,et al.  Expression of the Prothymosin-α Gene as a Prognostic Factor in Lung Cancer , 2001, Surgery Today.

[15]  J. Mesirov,et al.  Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Sugimachi,et al.  Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer. , 2001, Cancer research.

[17]  L. Giacomelli,et al.  p27kip1 Expression Is Associated With Tumor Response to Preoperative Chemoradiotherapy in Rectal Cancer , 2001, Annals of Surgical Oncology.

[18]  Yudong D. He,et al.  Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.

[19]  B. Iacopetta,et al.  Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer? , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Paul Dent,et al.  Signal Transduction and Cellular Radiation Responses , 2000, Radiation research.

[21]  D. Botstein,et al.  A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.

[22]  J. Puente,et al.  Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer , 2000, British Journal of Cancer.

[23]  R. Fietkau,et al.  Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. , 1998, International journal of radiation oncology, biology, physics.

[24]  C. Markopoulos,et al.  The prognostic value of alpha-thymosins in breast cancer. , 1998, Anticancer research.

[25]  P. Luna-Pérez,et al.  p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma , 1998, Annals of Surgical Oncology.

[26]  P. Reitsma,et al.  Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. , 1997, British Journal of Cancer.

[27]  K. Hess,et al.  p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[29]  M. Kusunoki,et al.  Significant effects of preoperative intraluminal brachytherapy on the survival rate after resection of rectal carcinoma. , 1996, International journal of oncology.

[30]  M. Buyse,et al.  Preoperative Radiotherapy as Adjuvant Treatment in Rectal Cancer: Final Results of a Randomized Study of the European Organization for Research and Treatment of Cancer (EORTC) , 1988, Annals of surgery.

[31]  J. Kofron,et al.  Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. , 2003, Science.

[32]  P. Hååg,et al.  Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. , 2001, Genomics.

[33]  S. Yun,et al.  p53, BCL-2, and Ki-67 Expression According to Tumor Response After Concurrent Chemoradiotherapy for Advanced Rectal Cancer , 2001, Annals of Surgical Oncology.

[34]  M. Mori,et al.  Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. , 1993, Oncogene.

[35]  J. Forteza,et al.  Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancer. , 1993, European journal of cancer.

[36]  M. Mori,et al.  Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer , 1993 .

[37]  Adjuvant therapy for patients with colon and rectal cancer. National Institutes of Health. , 1990, Connecticut medicine.

[38]  U. Metzger.  Adjuvant therapy for colon and rectal cancer. NIH Consensus Development Conference. , 1990, European journal of cancer.